首页> 美国卫生研究院文献>BMC Medicine >How effective is tetracaine 4 gel before a peripherally inserted central catheter in reducing procedural pain in infants: a randomized double-blind placebo controlled trial ISRCTN75884221
【2h】

How effective is tetracaine 4 gel before a peripherally inserted central catheter in reducing procedural pain in infants: a randomized double-blind placebo controlled trial ISRCTN75884221

机译:在外围插入中央导管之前丁卡因4%凝胶在减轻婴儿程序性疼痛方面的效果如何:一项随机双盲安慰剂对照试验ISRCTN75884221

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundProcedural pain relief is sub-optimal in infants, especially small and vulnerable ones. Tetracaine gel 4% (Ametop®, Smith-Nephew) provides pain relief in children and larger infants, but its efficacy in smaller infants and for peripherally inserted central catheters (PICC) remains uncertain. The objective of this trial was to assess the safety and efficacy of tetracaine gel on the pain response of very low birth weight (VLBW) infants during insertion of a PICC.
机译:背景程序性疼痛缓解在婴儿(尤其是小而脆弱的婴儿)中不是最佳的。 4%的四卡因凝胶(Ametop ®,Smith-Nephew)可减轻儿童和较大婴儿的疼痛,但其在较小婴儿和外围插入的中央导管(PICC)中的疗效仍不确定。该试验的目的是评估丁卡因凝胶在PICC插入期间对极低出生体重(VLBW)婴儿的疼痛反应的安全性和有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号